vs

Side-by-side financial comparison of MEDIFAST INC (MED) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $62.0M, roughly 1.2× MID PENN BANCORP INC). On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs -36.9%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $-6.6M). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.

MED vs MPB — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$62.0M
MPB
Growing faster (revenue YoY)
MPB
MPB
+67.7% gap
MPB
30.8%
-36.9%
MED
More free cash flow
MPB
MPB
$78.4M more FCF
MPB
$71.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
MPB
MPB
Annualised
MPB
21.1%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
MPB
MPB
Revenue
$75.1M
$62.0M
Net Profit
$19.4M
Gross Margin
69.4%
Operating Margin
-10.4%
43.6%
Net Margin
31.4%
Revenue YoY
-36.9%
30.8%
Net Profit YoY
47.0%
EPS (diluted)
$-1.64
$0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
MPB
MPB
Q4 25
$75.1M
$62.0M
Q3 25
$89.4M
$61.8M
Q2 25
$105.6M
$54.3M
Q1 25
$115.7M
$47.7M
Q4 24
$119.0M
$47.4M
Q3 24
$140.2M
$45.3M
Q2 24
$168.6M
$44.1M
Q1 24
$174.7M
$42.3M
Net Profit
MED
MED
MPB
MPB
Q4 25
$19.4M
Q3 25
$-2.3M
$18.3M
Q2 25
$2.5M
$4.8M
Q1 25
$-772.0K
$13.7M
Q4 24
$13.2M
Q3 24
$1.1M
$12.3M
Q2 24
$-8.2M
$11.8M
Q1 24
$8.3M
$12.1M
Gross Margin
MED
MED
MPB
MPB
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
MPB
MPB
Q4 25
-10.4%
43.6%
Q3 25
-4.6%
39.3%
Q2 25
-1.0%
7.9%
Q1 25
-1.1%
35.2%
Q4 24
0.6%
34.1%
Q3 24
1.5%
32.8%
Q2 24
-4.7%
32.4%
Q1 24
4.5%
34.8%
Net Margin
MED
MED
MPB
MPB
Q4 25
31.4%
Q3 25
-2.5%
29.6%
Q2 25
2.3%
8.8%
Q1 25
-0.7%
28.8%
Q4 24
27.9%
Q3 24
0.8%
27.1%
Q2 24
-4.8%
26.7%
Q1 24
4.8%
28.7%
EPS (diluted)
MED
MED
MPB
MPB
Q4 25
$-1.64
$0.83
Q3 25
$-0.21
$0.79
Q2 25
$0.22
$0.22
Q1 25
$-0.07
$0.71
Q4 24
$0.08
$0.72
Q3 24
$0.10
$0.74
Q2 24
$-0.75
$0.71
Q1 24
$0.76
$0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
MPB
MPB
Cash + ST InvestmentsLiquidity on hand
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$814.1M
Total Assets
$248.0M
$6.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
MPB
MPB
Q4 25
$167.3M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Stockholders' Equity
MED
MED
MPB
MPB
Q4 25
$198.9M
$814.1M
Q3 25
$214.7M
$796.3M
Q2 25
$216.0M
$775.7M
Q1 25
$211.0M
$667.9M
Q4 24
$210.1M
$655.0M
Q3 24
$207.3M
$573.1M
Q2 24
$205.3M
$559.7M
Q1 24
$211.0M
$551.0M
Total Assets
MED
MED
MPB
MPB
Q4 25
$248.0M
$6.1B
Q3 25
$268.2M
$6.3B
Q2 25
$269.3M
$6.4B
Q1 25
$280.0M
$5.5B
Q4 24
$284.2M
$5.5B
Q3 24
$291.2M
$5.5B
Q2 24
$293.5M
$5.4B
Q1 24
$302.8M
$5.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
MPB
MPB
Operating Cash FlowLast quarter
$-5.3M
$80.0M
Free Cash FlowOCF − Capex
$-6.6M
$71.8M
FCF MarginFCF / Revenue
-8.8%
115.8%
Capex IntensityCapex / Revenue
1.8%
13.3%
Cash ConversionOCF / Net Profit
4.12×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$132.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
MPB
MPB
Q4 25
$-5.3M
$80.0M
Q3 25
$12.1M
$26.3M
Q2 25
$-3.4M
$29.0M
Q1 25
$3.4M
$11.5M
Q4 24
$-4.9M
$51.4M
Q3 24
$9.1M
$16.9M
Q2 24
$13.1M
$18.0M
Q1 24
$7.3M
$12.4M
Free Cash Flow
MED
MED
MPB
MPB
Q4 25
$-6.6M
$71.8M
Q3 25
$10.8M
$24.3M
Q2 25
$-4.8M
$27.2M
Q1 25
$1.9M
$8.8M
Q4 24
$-7.2M
$44.5M
Q3 24
$7.7M
$16.8M
Q2 24
$11.1M
$17.7M
Q1 24
$5.4M
$12.1M
FCF Margin
MED
MED
MPB
MPB
Q4 25
-8.8%
115.8%
Q3 25
12.0%
39.4%
Q2 25
-4.5%
50.1%
Q1 25
1.6%
18.4%
Q4 24
-6.1%
93.8%
Q3 24
5.5%
37.1%
Q2 24
6.6%
40.2%
Q1 24
3.1%
28.5%
Capex Intensity
MED
MED
MPB
MPB
Q4 25
1.8%
13.3%
Q3 25
1.5%
3.1%
Q2 25
1.3%
3.2%
Q1 25
1.3%
5.7%
Q4 24
1.9%
14.6%
Q3 24
1.0%
0.0%
Q2 24
1.1%
0.7%
Q1 24
1.1%
0.8%
Cash Conversion
MED
MED
MPB
MPB
Q4 25
4.12×
Q3 25
1.44×
Q2 25
-1.36×
6.08×
Q1 25
0.84×
Q4 24
3.88×
Q3 24
8.04×
1.37×
Q2 24
1.53×
Q1 24
0.88×
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons